Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).

Saved in:
Bibliographic Details
Title: Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).
Authors: Tan X; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA. mxtz@novonordisk.com., Divino V; IQVIA, Falls Church, VA, USA., Amamoo J; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., Xie L; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., Coyle KB; IQVIA, Falls Church, VA, USA., Gamble CL; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., Guevarra M; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., Paprocki Y; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., King AA; Baptist Health System, San Antonio, TX, USA.
Source: Clinical drug investigation [Clin Drug Investig] 2024 Apr; Vol. 44 (4), pp. 271-284. Date of Electronic Publication: 2024 Mar 20.
Publication Type: Observational Study; Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1918
DOI:10.1007/s40261-024-01354-2